Covid-19: Sampling, Transport and Storage

Yıl 2020, , 70 - 75, 30.04.2020

Gülfem Ece , Mehmet Köroğlu

https://doi.org/10.34084/bshr.718968

Öz

Accurate collection and transportation of patient samples that meet the definition of suspicious patients are extremely important in the diagnosis of Covid-19. For this purpose, guidelines compatible with the infection prevention and control guidelines published by the World Health Organization have been developed. In this section, applications for Covid-19 sampling, methods, timing and transfer will be shared with current guides.

Anahtar Kelimeler

Covid-19, clinical sampling

Covid-19: Örnek Alinmasi, Taşinmasi ve Saklanmasi

Öz

Covid-19 tanısında şüpheli hasta tanımına uyan hasta örneklerinin doğru bir şekilde alınması ve transportu son derece önemlidir. Bu amaçla Dünya Sağlık Örgütünün yayınladığı enfeksiyon önleme ve kontrol klavuzlarına uyumlu rehberler geliştirilmiştir. Bu bölümde Covid-19 örnek alımı, yöntemleri, zamanlaması ve transferine yönelik uygulamalar güncel rehberler eşliğinde paylaşılacaktır.

Anahtar Kelimeler

Covid-19, örnek alma

Kaynakça

• 1. Global Surveillance for human infection with coronavirus disease (COVID-2019), Interim guidance, Geneva, World Health Organization, 2020. (https://www.who.int/publicationsdetail/ global-surveillance-for-humaninfection-withnovel-coronavirus-(2019-ncov
• 2. https://www.who.int/emergencies/diseases/novelcoronavirus2019/technical-guidance/laboratoryguidance
• 3. Wei -J G et al. Novel coronavirus infection in China.medRxiv preprint doi: https://doi.org/10.1101/2020.02.06.20020974
• 4. Quın L., et al. Early Transmission Dynamics in Wuhan, China,of Novel Coronavirus–Infected Pneumonia.N Eng Jour Med.January 29, 2020.
• 5. Linton N.M. at al Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.J. Clin. Med. 2020, 9(2), 538; https://doi.org/10.3390/jcm9020538.
• 6. XU K., et al. Management of Corona Virus Disease-19 (COVID-19): the Zhejiang Experience. Jour Zhejiang Univ. DOI：10.3785/j.issn.1008- 9292.2020.02.02.
• 7. Wei Z. At al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes, Emerging Microbes & Infections,9:1, 386-389 (https://www.tandfonline.com/doi/full/101080/22221751.2020.1729071).
• 8. Yong Z. et al. Isolation of 2019-nCoV from a Stool Specimen of a Laboratory-Confirmed Case of the Coronavirus Disease 2019 (COVID19), 2020, CCDC Weekly / Vol. 2/ No. 8
• 9. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, interim guidance, January 2020
• 10. WHO interim guidance for laboratory biosafety related to 2019-nCoV.
• 11. WHO Guidance on regulations for the Transport of Infectious Substances 2019-2020
• 12. Protocol to investigate non-seasonal influenza and other emerging acute respiratory diseases. Geneva: World Health Organization; 2018(https://www.who.int/influenza/resources/publications/outbreak_investigation_protoco l/en/).
• 13. Bruce et al. JCM. 2011. Evaluation of Swabs, Transport Media, and Specimen Transport Conditions for Optimal Detection of Viruses by PCR.
• 14. https://hsgm.saglik.gov.tr/depo/kurumsal/plan-ve-faaliyetler/numune-alma-el- kitabi.pdf (Erişim tarihi: 10.04.2020)